Unimed settles patent litigation over AndroGel (Pharmaceutical Business Review)
Unimed settles patent litigation over AndroGel (Pharmaceutical Business Review)
Unimed Pharmaceuticals, a subsidiary of Solvay Pharmaceuticals, has announced that it has settled all pending patent litigation over a generic version of its testosterone gel, AndroGel.